Page 3 - Rating Scale News Today

Local officials and university researchers hope the development of a blizzard rating scale is something that would be further tweaked and adopted statewide or even farther.

PDUFA target action date set to occur by December 8, 2023 NEW YORK, June 6, 2023 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. , a leading developer of adult stem cell therapeutics for... | June 6, 2023

Researchers continue to search for life-altering treatments for neurodegenerative diseases that will lead to significantly improved patient outcomes.

Potent and durable target engagement observed across cohorts, including with 10 mg doses administered every 12 weeks which were also generally safe and well-tolerated WVE-004 did not show clinical... | May 23, 2023

Patients treated with Eli Lilly Alzheimer’s disease drug donanemab showed a 35% slowing in decline compared to those given a placebo. Based on the Phase 3 results, Lilly said it would seek FDA approval for the drug by the end of June.

Trial's long-term follow-up fills gap left from primary analysis

Cytokinetics is ending the COURAGE-ALS trial evaluating reldesemtiv for the treatment of amyotrophic lateral sclerosis.

Cytokinetics is ending the COURAGE-ALS trial evaluating reldesemtiv for the treatment of amyotrophic lateral sclerosis.

Company Plans to Discontinue the Phase 3 Clinical Trial of Reldesemtiv After Data Monitoring Committee Found No Effect on Primary or Key Secondary Endpoints Cytokinetics to Host Conference Call and... | March 31, 2023

Optimize your survey responses by including a likert scale to derive customer insights and feedback on specific topics.